当前位置:首页 - 行情中心 - 亚虹医药-U(688176) - 财务分析

亚虹医药-U

(688176)

  

流通市值:42.44亿  总市值:55.63亿
流通股本:4.36亿   总股本:5.71亿

亚虹医药-U(688176)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润-2.61亿元,每股收益-0.44元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益173620.67万元,未分配利润-167756.20万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产214870.00万元,负债41249.33万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入216,408,302.14130,237,475.1361,101,125.72201,562,432.59
营业总成本492,121,292.52315,289,508.12152,883,339.26609,000,649.86
其他经营收益
营业利润-258,185,335.83-167,498,407.9-85,719,477.84-383,805,943.59
利润总额-261,643,797.65-170,534,193.48-86,391,242.73-386,795,826.88
净利润-261,050,841.03-170,012,214.31-86,341,679.22-386,000,059.67
每股收益
其他综合收益244,644.07824,831.05-52,203.72-5,208,757.06
综合收益总额-260,806,196.96-169,187,383.26-86,393,882.94-391,208,816.73
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计1,831,875,409.941,853,436,367.241,780,132,063.571,530,945,418.21
非流动资产:
非流动资产合计316,824,572.54321,224,052.73381,431,167.4692,046,485.58
资产总计2,148,699,982.482,174,660,419.972,161,563,230.972,222,991,903.79
流动负债:
流动负债合计367,297,502.27312,730,467.19221,202,487.62197,059,830.76
非流动负债:
非流动负债合计45,195,805.9847,072,296.7351,104,994.1955,558,274.53
负债合计412,493,308.25359,802,763.92272,307,481.81252,618,105.29
所有者权益(或股东权益):
归属于母公司股东权益合计1,744,502,159.341,819,476,153.991,890,799,054.311,969,405,336.09
股东权益合计1,736,206,674.231,814,857,656.051,889,255,749.161,970,373,798.5
负债和股东权益合计2,148,699,982.482,174,660,419.972,161,563,230.972,222,991,903.79
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计216,356,522.64136,005,902.2761,061,157.83195,899,049.99
经营活动现金流出小计518,155,423.76330,277,080.67171,418,315.44620,849,902.16
经营活动产生的现金流量净额-301,798,901.12-194,271,178.4-110,357,157.61-424,950,852.17
投资活动产生的现金流量:
投资活动现金流入小计4,558,419,963.773,333,733,553.91,534,792,114.972,395,262,459.83
投资活动现金流出小计4,618,713,630.263,373,608,447.241,215,228,607.381,598,008,544.96
投资活动产生的现金流量净额-60,293,666.49-39,874,893.34319,563,507.59797,253,914.87
筹资活动产生的现金流量:
筹资活动现金流入小计239,359,346.39167,647,243.7277,290,00066,200,000
筹资活动现金流出小计58,270,569.8146,701,462.6141,572,485.23143,210,871.59
筹资活动产生的现金流量净额181,088,776.58120,945,781.1135,717,514.77-77,010,871.59
汇率变动对现金及现金等价物的影响-385,166.51-308,215.120,225.13-1,954,293.65
现金及现金等价物净增加额-181,388,957.54-113,508,505.73244,944,089.88293,337,897.46
期末现金及现金等价物余额439,246,008.57507,126,460.38865,579,055.99620,634,966.11
补充资料:
现金及现金等价物的净增加额--113,508,505.73-293,337,897.46
最新报告期:2025-10-31
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
西南证券杜向阳,汤泰萌-0.75-0.76-0.762025-10-31
太平洋周豫-0.57-0.44-0.122025-09-01
财通证券华挺-0.36-0.100.172025-08-30
西南证券杜向阳,汤泰萌-0.75-0.76-0.712025-08-29
TOP↑